-
GLAUCOMA Research Foundation Appoints Julie S. Austin, MNO, Vice President of Philanthropy
- August 10, 2026
- Posted by:
- Category: Finance & accounting
No Comments
SAN FRANCISCO, July 30, 2026 /PRNewswire/ — Glaucoma Research Foundation (GRF) today announced the appointment of Julie S. Austin, MNO, Vice President Philanthropy. In this role, Austin will lead GRF’s major and principal gifts program, expand a national…
-
Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China
- August 10, 2026
- Posted by: Brian Sullivan
- Category: Finance & accounting
Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AMLSAN FRANCISCO and SUZHOU, China, Aug. 9, 2026 /PRNewswire/ — Innovent Biologics, Inc. (01801.HK) and Daiichi Sankyo (TSE: 4568), have entered into an exclusive agreement…
-
Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections
- August 10, 2026
- Posted by: Brian Sullivan
- Category: Finance & accounting
SHANGHAI, Aug. 9, 2026 /PRNewswire/ — Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces that its wholly-owned subsidiary T-mab has successfully passed Brazilian Health Regulatory Agency’s (“ANVISA”) GMP on-site inspection for its…